Cargando…

Are the COVID-19’s vaccines efficient on the most dangerous variant of SARS-CoV-2?

Detalles Bibliográficos
Autores principales:	Davoodi, Poorya, Hashemi, Atousa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Vaccine Society 2021
Materias:	COVID-19 Special
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511588/ https://www.ncbi.nlm.nih.gov/pubmed/34703817 http://dx.doi.org/10.7774/cevr.2021.10.3.301

Ejemplares similares

SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants
por: Syahniar, Rike, et al.
Publicado: (2022)

SARS-CoV-2 vaccine-related neurological complications
por: Oonk, Nicol G. M., et al.
Publicado: (2022)

Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19
por: Alshebri, Munirah Saad, et al.
Publicado: (2020)

Assessment on anti-SARS-CoV-2 receptor-binding domain antibodies among CoronaVac-vaccinated Indonesian adults
por: Jo, Juandy, et al.
Publicado: (2022)

Viral shedding patterns of symptomatic SARS-CoV-2 infections by periods of variant predominance and vaccination status in Gyeonggi Province, Korea
por: Choi, Gawon, et al.
Publicado: (2022)

Occurrence of the Omicron variant of SARS-CoV-2 in northern Viet Nam in early 2022
por: Ung, Trang thi Hong, et al.
Publicado: (2022)

ADEM anti-MOG antibody-positive after SARS-CoV2 vaccination
por: Mumoli, Laura, et al.
Publicado: (2021)

Isolated musculocutaneous involvement in neuralgic amyotrophy associated with SARS-CoV2 vaccination
por: Civardi, Carlo, et al.
Publicado: (2022)

Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia
por: Trunfio, Mattia, et al.
Publicado: (2022)

Air filtration and SARS-CoV-2
por: Nazarenko, Yevgen
Publicado: (2020)

Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity
por: Delmonte, Ottavia M., et al.
Publicado: (2021)

Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination
por: Kwon, Hyeryung, et al.
Publicado: (2021)

Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events
por: Ng, Siew C, et al.
Publicado: (2022)

COVID-19 Vaccination Associated With Reduced Postoperative SARS-CoV-2 Infection and Morbidity
por: Prasad, Nikhil K., et al.
Publicado: (2022)

Safety of SARS-CoV-2 vaccines in patients with myasthenia gravis: a meta-analysis
por: Zheng, Qian, et al.
Publicado: (2023)

Clinical severity according to the primary infection variant in patients with suspected SARS-CoV-2 reinfection in Korea
por: Hwang, Myung-Jae, et al.
Publicado: (2022)

Infections sévères à SARS-CoV-2
por: Taghboulit, N., et al.
Publicado: (2021)

Simultaneous analysis of antigen‐specific B and T cells after SARS‐CoV‐2 infection and vaccination
por: Newell, Krista L., et al.
Publicado: (2022)

Association between stopping universal SARS-CoV-2 admission testing and hospital-onset SARS-CoV-2 in England and Scotland
por: Pak, Theodore, et al.
Publicado: (2023)

Large inter-individual variability of cellular and humoral immunological responses to mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in health care workers
por: Krüttgen, Alexander, et al.
Publicado: (2022)

Dynamics of hospitalizations and in-hospital deaths from COVID-19 in northeast Brazil: a retrospective analysis based on the circulation of SARS-CoV-2 variants and vaccination coverage
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2022)

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022)

Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy
por: Syversen, Silje W., et al.
Publicado: (2022)

The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective
por: Wong, Rebecca S. Y.
Publicado: (2020)

Diaphragmatic myoclonus due to SARS-CoV-2 infection
por: Borroni, Barbara, et al.
Publicado: (2020)

SARS-CoV-2, an Underestimated Pathogen of the Nervous System
por: Jakhmola, Shweta, et al.
Publicado: (2020)

A Cluster of Aspergillosis Associated with SARS-CoV-2
por: VerLee, Kerrie, et al.
Publicado: (2021)

Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2
Publicado: (2022)

Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant
por: Abraham, Roshini S., et al.
Publicado: (2021)

SARS-CoV-2 vaccination, Parkinson’s disease, and other movement disorders: case series and short literature review
por: Imbalzano, Gabriele, et al.
Publicado: (2022)

New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series
por: Fanella, Gaia, et al.
Publicado: (2022)

Outcomes of patients hospitalized for COVID-19, secondary infections, antimicrobial use during SARS-CoV-2 delta and omicron variants
por: Srialluri, Swetha, et al.
Publicado: (2023)

The Evidence for High-Titer Convalescent Plasma in SARS-CoV-2
por: Fisher, David L., et al.
Publicado: (2021)

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
por: Reicher, Shay, et al.
Publicado: (2021)

Broken Heart (Takotsubo) Syndrome Triggered by SARS-CoV-2
por: Finsterer, Josef
Publicado: (2021)

Asthma and viruses: A focus on rhinoviruses and SARS-CoV-2
por: Padayachee, Yorissa, et al.
Publicado: (2021)

Seroepidemiology of SARS-CoV-2, Yamagata, Japan, June 2020
por: Morikane, Keita, et al.
Publicado: (2021)

Cognitive phenotyping of post-infectious SARS-CoV-2 patients
por: Aiello, Edoardo Nicolò, et al.
Publicado: (2022)

Humoral and Cellular Immune Responses to SARS–CoV‐2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion
por: Simon, David, et al.
Publicado: (2021)

A cluster of tertiary transmissions of 2019 novel coronavirus (SARS-CoV-2) in the community from infectors with common cold symptoms
por: Kim, Nam Joong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ijub6ueltbm34gufj7qs9el3hp